ID16274A - Antagonis bradikinin heterosiklik pengganti-fluoroalkil dan fluoroalkoksi, proses pembuatan dan pemakaiannya - Google Patents

Antagonis bradikinin heterosiklik pengganti-fluoroalkil dan fluoroalkoksi, proses pembuatan dan pemakaiannya

Info

Publication number
ID16274A
ID16274A IDP970863A ID970863A ID16274A ID 16274 A ID16274 A ID 16274A ID P970863 A IDP970863 A ID P970863A ID 970863 A ID970863 A ID 970863A ID 16274 A ID16274 A ID 16274A
Authority
ID
Indonesia
Prior art keywords
heterosiclic
fluoroalcyl
fluoroalcocy
production process
antagonist analysis
Prior art date
Application number
IDP970863A
Other languages
English (en)
Indonesian (id)
Inventor
Adalbert Dr Wagner
Holger Dr Heitsch
Gerhard Dr Nolken
Klaus Dr Wirth
Bernward Prof Dr Scholkens
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ID16274A publication Critical patent/ID16274A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/24—Oxygen atoms attached in position 8
    • C07D215/26—Alcohols; Ethers thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/08—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/10—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D257/12—Six-membered rings having four nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IDP970863A 1996-03-19 1997-03-17 Antagonis bradikinin heterosiklik pengganti-fluoroalkil dan fluoroalkoksi, proses pembuatan dan pemakaiannya ID16274A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19610784A DE19610784A1 (de) 1996-03-19 1996-03-19 Fluoralkyl- und Fluoralkoxysubstituierte heterocyclische Bradykinin-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
ID16274A true ID16274A (id) 1997-09-18

Family

ID=7788755

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP970863A ID16274A (id) 1996-03-19 1997-03-17 Antagonis bradikinin heterosiklik pengganti-fluoroalkil dan fluoroalkoksi, proses pembuatan dan pemakaiannya

Country Status (24)

Country Link
US (1) US5859025A (fr)
EP (1) EP0796848B1 (fr)
JP (1) JP4199315B2 (fr)
KR (1) KR970065522A (fr)
AR (1) AR006261A1 (fr)
AT (1) ATE242215T1 (fr)
AU (1) AU1628397A (fr)
BR (1) BR9701332A (fr)
CA (1) CA2199925A1 (fr)
CZ (1) CZ81097A3 (fr)
DE (2) DE19610784A1 (fr)
DK (1) DK0796848T3 (fr)
ES (1) ES2196207T3 (fr)
HR (1) HRP970155A2 (fr)
HU (1) HUP9700595A1 (fr)
ID (1) ID16274A (fr)
IL (1) IL120477A0 (fr)
NO (1) NO971238L (fr)
PL (1) PL318924A1 (fr)
PT (1) PT796848E (fr)
SI (1) SI0796848T1 (fr)
SK (1) SK34897A3 (fr)
TR (1) TR199700206A2 (fr)
ZA (1) ZA972328B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19712960A1 (de) * 1997-03-27 1998-10-01 Hoechst Ag Benzyloxy-substituierte, anellierte N-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Bradykininrezeptorantagonisten
ATE257479T1 (de) * 1999-12-10 2004-01-15 Pfizer 5-ring heteroarylsubstituierte 1,4- dihydropyridine als bradykinin antagonisten
EP1495017A2 (fr) * 2002-04-10 2005-01-12 Ortho-McNeil Pharmaceutical, Inc. Nouveaux derives heteroarylalkylamide utiles en tant que modulateurs du recepteur de la bradykinine
EP1914236A1 (fr) 2002-04-10 2008-04-23 Ortho-McNeil Pharmaceutical, Inc. Nouveaux dérivés d'hétéroarylalkylamide utiles en tant que modulateurs du récepteur de la bradykinine
ITMI20021247A1 (it) * 2002-06-07 2003-12-09 Menarini Ricerche Spa Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
US7256207B2 (en) * 2003-08-20 2007-08-14 Irm Llc Inhibitors of cathepsin S
KR20070116060A (ko) 2005-03-01 2007-12-06 와이어쓰 신놀린 화합물 및 간 ｘ 수용체 조절제로서의 이의 용도
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽ｂ２受體調節劑
AR085073A1 (es) * 2012-01-11 2013-09-11 Richmond Sa Com Ind Y Financiera Lab Compuestos con actividad antibacteriana, un procedimiento para su obtencion y composiciones farmaceuticas que los comprenden
IL274883B2 (en) 2017-11-24 2023-11-01 Pharvaris Netherlands B V BRADYKININ B2 receptor antagonists
AR118982A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
UY38707A (es) 2019-05-23 2020-12-31 Pharvaris Gmbh Nuevos antagonistas cíclicos del receptor b2 de bradiquinina
BR112024002215A2 (pt) 2021-08-05 2024-04-30 Pharvaris Gmbh Composição à base de lipídios para administração oral de antagonistas do receptor b2 da bradicinina
TW202345810A (zh) 2022-03-25 2023-12-01 瑞士商帕法瑞斯有限責任公司 包含緩激肽ｂ２受體拮抗劑之固態延長釋放組成物
HRP20260166T1 (hr) 2022-03-25 2026-03-27 Pharvaris Gmbh Čvrsti sastav koji sadrži solubilizirane antagoniste bradikinin b2 receptora
EP4499100A1 (fr) 2022-03-25 2025-02-05 Pharvaris GmbH Utilisations thérapeutiques d'antagonistes du récepteur b2 de la bradykinine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216165A (en) * 1990-10-03 1993-06-01 American Home Products Corporation N-substituted aminoquinolines as analgesic agents
US5212182A (en) * 1990-10-03 1993-05-18 American Home Products Corpooration Substituted quinolinyl- and naphthalenylbenzamides or benzylamines and related compounds useful as analgesics
US5438064A (en) * 1991-12-23 1995-08-01 American Home Products Corporation Derivatives of 4-anilinoquinoline-3-carboxamide as analgesic agents
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
WO1996005202A1 (fr) * 1994-08-17 1996-02-22 Nippon Hypox Laboratories Inc. Derive de l'imidazoquinoleine
WO1996013485A1 (fr) * 1994-10-27 1996-05-09 Fujisawa Pharmaceutical Co., Ltd. Pyridopyrimidones, quinoleines et heterocycles azotes fusionnes comme antagonistes de la bradykinine

Also Published As

Publication number Publication date
PL318924A1 (en) 1997-09-29
BR9701332A (pt) 1998-08-18
NO971238L (no) 1997-09-22
PT796848E (pt) 2003-08-29
DK0796848T3 (da) 2003-09-22
EP0796848B1 (fr) 2003-06-04
AR006261A1 (es) 1999-08-11
JPH107656A (ja) 1998-01-13
HU9700595D0 (en) 1997-05-28
TR199700206A2 (xx) 1997-10-21
HRP970155A2 (en) 1998-04-30
AU1628397A (en) 1997-09-25
NO971238D0 (no) 1997-03-18
SK34897A3 (en) 1998-01-14
DE19610784A1 (de) 1997-09-25
CA2199925A1 (fr) 1997-09-19
ATE242215T1 (de) 2003-06-15
ES2196207T3 (es) 2003-12-16
HUP9700595A1 (hu) 2000-08-28
IL120477A0 (en) 1997-07-13
SI0796848T1 (en) 2003-12-31
EP0796848A1 (fr) 1997-09-24
JP4199315B2 (ja) 2008-12-17
CZ81097A3 (en) 1997-10-15
MX9702028A (es) 1997-09-30
KR970065522A (ko) 1997-10-13
US5859025A (en) 1999-01-12
DE59710191D1 (de) 2003-07-10
ZA972328B (en) 1997-09-19

Similar Documents

Publication Publication Date Title
ID19290A (id) Turunan-turunan propiofenon dan proses pembuatannya
ID26207A (id) ESTRATRIENA TERSUBSTITUSI 11β-HALOGEN-7 αTERSUBSTITUTASI, PROSES UNTUK MEMPRODUKSI SEDIAAN FARMASI YANG MENGANDUNG ESTRATRIENA 11β-HALOGEN-7 αINI DAN JUGA PENGGUNAANNYA UNTUK PRODUKSI ZAT-ZAT FARMASI
ID22821A (id) Turunan sulfonamida, proses pembuatannya dan penggunaannya sebagai obat
ID22852A (id) Bahan-bahan biokontrol antifungi, proses untuk membuatnya dan memperlakukannya
ID17307A (id) Komposisi oral dan proses pembuatannya.
ID28728A (id) Komposisi dan proses pengkrepan
ID24255A (id) Proses pembuatan dengan aroma tajam
ID17524A (id) Proses pemanfaatan penyerapan tekana vakum ayun
FI963904L (fi) Tuote, menetelmä sen valmistamiseksi ja sen käyttö
ID19253A (id) Bahan antagonis reseptor vitronektin, pembuatannya dan penggunaannya
ID30506A (id) Proses pengembangan ko-produksi 6-aminokapronitril dan heksametilenadiamino
ID24714A (id) Turunan tiazolidindion tersubstitusi, proses pembuatannya dan penggunaan bahan farmasinya
ID21337A (id) Katalis terdorong, proses pembuatannya, dan penggunaannya dalam oksiklorinasi etilene
ID27275A (id) Intermediet dan proses untuk pembuatan olanzapin
ID22641A (id) Proses pembuatan e-kaprolaktam
ID19245A (id) Antagonis reseptor vitronektin, pembuatannya dan pemakaiannya
ID23316A (id) Proses karbonilasi
ID19678A (id) Proses dan alat pemisahan gas
ID18954A (id) Kopolimer, proses terhidrogenasi daripadanya, dan proses untuk memproduksinya
ID23304A (id) Turunan-turunan diaza-spiro [3,5] nonana, proses pembuatan dan penggunaannya
ID16217A (id) Aminoalkil dan asilaminoalkil eter, proses untuk pembuatannya, dan pemakaiannya sebagai antagonis reseptor bradykinin
ID26660A (id) Proses pembuatan butana-1,4-diol, gamma-butirolakton dan tetrahidrofuran
ID24173A (id) 1,2,3,4,5,6 heksahidro-2-6-metano-3-benzazosin-10-ol, proses pembuatan dan penggunannya untuk obat-obatan
ID26344A (id) Pakaian atas sekali pakai dan proses pembuatannya
ID18817A (id) 3-amidokromanilsulfonil (tio) urea, proses untuk pembuatan, penggunaan, dan sediaan-sediaan farmasi yang mengandungnya